Sandbox:Infectious Balanitis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Vishal Devarkonda, M.B.B.S[2]
Synonyms and keywords:BXO, Penile lichen sclerosus
Overview
Historical Perspective
Classification
Pathophysiology
- Fusospirochetes were isolated more frequently in the patients who practiced orogenital sex or used saliva as a lubricant during coitus
- tight foreskin and sub-optimal hygiene.
- Presence of a tight foreskin and phimosis seems to be a prerequisite for this condition to develop. Hygienic practices were poor in most case reports and in both of our patients. Chakraborty and Data showed an association between low socioeconomic status and development of infectious balanoposthitis in general, and contamination with saliva and isolation of Fusarium spp. in particular [11]. Anaerobic Gram-negative rods produce various toxins, proteases, elastase, and other virulence factors [19,20]. Porphyromonas asaccharolytica, Prevotella intermedia, and P. melaninogenica have been shown to cleave lgA1. In addition, P. asaccharolytica and P. intermedia can cleave lgG [21]. The implication of these pathogenic properties and the interactions they may cause with the host remain to be studied. There are case reports of severe balanoposthitis in neutropenic patients caused by aerobic Gram-negative rods and Candida balanitis is associated with diabetes, but we could not find an association between anaerobic balanoposthitis and any systemic diseases [22,23]
Causes
Infectious causes of Balanitis | |
---|---|
Bacterial |
Anaerobic bacteriaGardnerella vaginalis `Bacteroides melaninogenicus unidentified Bacteroides Bacteroides fr agilis Fusobacterium spp Aerobic bacteriaGroup B streptococci Group A haemolytic streptococci Staphyloccocus aureus Mycobacterium tuberculosis Mycobacterium leprae Borrelia burgdorferi Borrelia vincenti Neisseria gonorrhea |
Viral |
Human papilloma virus
Herpes simplex virus Human immunodeficiency virus |
Fungal |
Candida
Malassezia furfur, |
Parasitic |
Entamoeba histolytica
Trichomonas |
Epidemiology and Demographics
Screening
There is no scre
Natural History, Complications, and Prognosis
Natural history
Complications
Prognosis
Diagnosis
Clinical features of Infectious balanitis | |
---|---|
Candidal Balanitis | Erythematous rash with soreness and/or itch, blotchy erythema with small papules which may be eroded, or dry dull red areas with a glazed appearance |
Anaerobic Infection | Foul smelling sub-preputial inflammation and discharg: in severe cases associated with swelling and inflamed inguinal lymph nodes
Preputial edema, superficial erosions: milder forms also occur |
Aerobic
Infections |
Variable inflmmatory changes including uniform erythema and edema |
T. vaginalis | Superficial erosive balanitis which may lead to phimosis |
TP | Multiple circinate lesions which erode to cause irregular ulcers have been described in the late primary or early secondary stage. A primary chancre may also be present |
Herpes simplex | Grouped vesicles on erythematous base over glans, prepuce and shaft which rupture to form shallow erosins. In rare cases primary herpes can cause a necrotic balanitis, with necrotic areas on the glans accompained by vesicles elsewhere and associated with headache and malaise. |
Human papilloma virus | Papilloma virus may be associated with patchy or chronic balanitis, which becomes acetowhite after the application of 5% acetic acid |
Laboratory findings
Laboratory findings | |
---|---|
Candidal Balanitis | Urinalysis for glucose
Sub-preputial culture/swab for primary candidasis/candidal superinfection-to be done in all cases Investigation for HIV or other causes of immunosuppression |
Anaerobic Infection |
|
Aerobic
Infections |
Sub-preputial culture
Streptococci spp. and S. aureus have both been reported as causing balanitis |
T. vaginalis | Wet preparation from the subpreputial sac demonstrates the organism
Culture and NAAT can also be carried out |
TP | Dark field microscopy, TP NAAT and DFA-TP will confirm the diagnosis. This should ideally be done every case.
TPHA coupled with nontreponemal serological tests though of limited value, should be performed since they are useful for follow-up |
Herpes simplex | Tissue scraping from base of erosion subjected to Tzanck smear IgG and IgM for HSV cell culture and PCR-preferred HSV tests for persons who seek medical treatment for gential ulcers or other mucocutaneous lesions |
Human papilloma virus | Diagnosed clinically |
Treatment
Laboratory findings | ||
---|---|---|
Preferred regimen | Alternative regimen | |
Candidal Balanitis | Clotimazole cream 1%
Miconazole cream 2% |
Fluconazole 150 mg stat orally
Nystatin cream-if resistance suspected topical clotrimazole/miconazole with 1% hydrocortisone-if marked inflammation |
Anaerobic Infection | Advice about genital hygiene
metronidazole 400 mg twice daily for 1 week Milder cases- topical metronidazole |
Coamoxiclav(amoxycillin/clavulanic acid) 375 mg 3 times daily for 1 week
Clindamycin cream applied twice daily until resolved |
Aerobic
Infections |
Usually topical
Triple combination (clotrimazole 1%, beclometasone dipropionate 0.025%, gentamicinsilfate 0.3%) applied once daily Severe cases-systemic antibiotics Erythromycin 500 mg QDS for 1 week Co-amoxiclav(amoxycillin/clvulanic acid 375 mg 3 times daily for 1 week |
Alternative regimens depend on the sensitivities of the organisms isolated |
T. vaginalis | Metronidazole 2 g orally single dose
Secidazole 2 g orally single dose |
Metronidazole 400 mg orally twice a day for 7 days |
TP | Single IM administration of 2.4 MU of benzathine penicillin
Doxycycline 100 mg orally BID for 2 weeks or Tetracycline 500 mg orally QID for 2 weeks or Erythromycin 500 mg QID or Ceftriaxone 1 g IM/IV daily for 8-10 days |
|
Herpes simplex | Acyclovir 400 mg orally 3 times a day for 7-10 days or
Acyclovir 200 mg orally 5 times a day for 7-10 days or Famciclovir 250 mg orally 3 times a day for 7-10 days or Valacyclovir 1 g orally twice a day for 7-10 days |
|
Human papilloma virus | Patients appiled
Podophyllotoxin(podofilox) 0.5% or gel-twice daily for three consecutive days, but no more than 4 weeks or Imiquimod 5% cream-applied at bedtime 3 times/week for a maximum of 16 weeks, and must be left in place for 6-10 h following application or Sinecatechins 15% ointment Provider-administered Podophyllin resin 20% in a compound tincture of benzoin-once a week for 6-8 week or Cryotherapy with liquid nitrogen ot cryoprobe. Repeat applications every 1-2 wees or TCA/bichloroacetic acid-80-90% once per week for an average course of 6-10 weeks or Surgical removal either by tangential scissor excision, tangential shave excision, curettage, or electrourgery. |